<?xml version="1.0" encoding="UTF-8"?>
<p id="Par38">To judge the feasibility of chest CT in COVID-19 screening, other factors have to be considered. In the use of chest CT as a first-line screening tool in large population, the risk-benefit ratio should be considered. Medical imaging is the largest man-made source of exposure that is about 0.6 mSv/year [
 <xref ref-type="bibr" rid="CR20">20</xref>]. A standard-dose chest CT is in the range of 1.8 mSv, but low-dose protocol was shown to be effective identifying COVID-19 infection that has a dose about 0.2 mSv [
 <xref ref-type="bibr" rid="CR21">21</xref>]. Introducing chest CT on a large-scale in the diagnosis of COVID-19 would increase the radiation exposure of the population significantly.
</p>
